Literature DB >> 13734422

Clinical use of 6-aminonicotinamide in patients with disseminated neoplastic disease.

C P PERLIA, S KOFMAN, H SKY-PECK, S G TAYLOR.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13734422     DOI： 10.1002/1097-0142(199005/06)14:3<644::aid-cncr2820140328>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

1.  [Morphological findings in the central nervous system of the rat after poisoning with antimetabolites of nicotinamide (6-aminonicotinamide and 3-acetylpyridine) and a quinoline derivative (5-nitro-8-hydroxyquinoline)].

Authors:  H Schneider; H Coper
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1968-08-22

2.  [The biosynthesis of pyridinenucleotides of abnormal structure in tumors].

Authors:  H Coper; H Hadass; R Salazar
Journal:  Z Krebsforsch       Date:  1967

3.  Some metabolic and morphological alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide.

Authors:  N Ofori-Nkansah; F von Bruchhausen
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

4.  Metabolic alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide and prevented by nicotinamide.

Authors:  N Ofori-Nkansah; F von Bruchhausen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.

Authors:  Fang Ren; Xiao Yang; Zhong-Wen Hu; Vincent Kam Wai Wong; Hong-Yan Xu; Ji-Hua Ren; Shan Zhong; Xiao-Jiong Jia; Hui Jiang; Jie-Li Hu; Xue-Fei Cai; Wen-Lu Zhang; Fang-Long Yao; Hai-Bo Yu; Sheng-Tao Cheng; Hong-Zhong Zhou; Ai-Long Huang; Betty Yuen Kwan Law; Juan Chen
Journal:  EBioMedicine       Date:  2019-10-31       Impact factor: 8.143

Review 6.  Clinical significance of T cell metabolic reprogramming in cancer.

Authors:  Christoph Herbel; Nikolaos Patsoukis; Kankana Bardhan; Pankaj Seth; Jessica D Weaver; Vassiliki A Boussiotis
Journal:  Clin Transl Med       Date:  2016-08-10

7.  Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.

Authors:  Ida Sofie Grønningsæter; Håkon Reikvam; Elise Aasebø; Sushma Bartaula-Brevik; Tor Henrik Tvedt; Øystein Bruserud; Kimberley Joanne Hatfield
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.